Health
CVS and Walgreens will start selling abortion pills this month
CVS and Walgreens, the two largest US pharmacy chains, will begin selling mifepristone abortion pills in shops in several states this month, drawing praise from
Bayer to purchase a heart drug for up to $310 million
Bayer said Monday it has acquired exclusive marketing rights in Europe for a new drug under regulatory review to treat a rare, potentially fatal heart
FDA approves J&J combination therapy to treat a type of lung cancer
A US health regulator has approved Johnson & Johnson’s Uterapia in combination with other chemotherapy drugs for the first-line treatment of lung cancer. The FDA
More than one billion people are obese worldwide
According to World Health Organisation estimates, more than one billion people worldwide are considered obese, a condition associated with an increased risk of many serious
Missouri accuses Planned Parenthood of “trafficking” minors for abortions
Missouri’s Republican attorney general sued a Planned Parenthood affiliate, accusing it of helping minors travel to Kansas for abortions without telling their parents, in violation
Gaza’s health system is “more than on its knees”, WHO says
“The system in Gaza is on its knees, more than on its knees,” WHO spokesman Christian Lindmeier told reporters in Geneva. “All the lifelines in
South Korea’s trainee doctors defy pressure to end strike
Thousands of South Korean trainee doctors are refusing to return to work on Thursday, the government’s deadline for ending a massive strike, warning that the
GSK settles another lawsuit over heartburn drug Zantac in California
GSK has agreed to confidentially settle another lawsuit in California alleging that the discontinued heartburn drug Zantac caused cancer, the latest in a series of
Sandoz enters $265 million settlement in US collusion case
Sandoz announced Thursday that it has settled a collusion case in the United States. The company said its US subsidiaries have agreed to pay $265
US FDA to step up inspections of drug manufacturing facilities in India
The US drug regulator is set to increase inspections at Indian drug manufacturing facilities in 2024 amid growing concerns over drug quality, a top Food